VulnerabilityAnalyzed
CVE-2025-62575
This can lead to remote code execution through the use of certain built-in stored procedures.
HIGH 8.7EPSS 0.42%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.42%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
NMIS/BioDose V22.02 and previous versions rely on a Microsoft SQL Server database. The SQL user account 'nmdbuser' and other created accounts by default have the sysadmin role. This can lead to remote code execution through the use of certain built-in stored procedures.
- CVSS 4.0
- 8.7 HIGHCVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/M
- EPSS
- 0.42% probability · 35th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-732
- Affected
- mirion/biodose\/nmis
- Source
- ics-cert@hq.dhs.gov
References
- https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.